How many SEC Form 4 insider filings does CTOR have?

CITIUS ONCOLOGY, INC. (CTOR) has 20 SEC Form 4 filings (20 transaction rows) in the rolling 365-day window, disclosed by 0 distinct insiders. Most recent filing: Dec 22, 2025.

When was the most recent SEC Form 4 filing for CTOR?

The most recent Form 4 filing for CTOR on Tracefour is dated Dec 22, 2025.

CTOR

Name: CTOR Insider Trading Activity
Creator: Tracefour
License: https://www.usa.gov/government-works
Keywords: CTOR, insider trading, SEC Form 4, insider transactions

CITIUS ONCOLOGY, INC.

CITIUS ONCOLOGY, INC. (CTOR) has 20 SEC Form 4 filings (20 transaction rows) in the rolling window, disclosed by 0 distinct insiders. Most recent filing: Dec 22, 2025.

Industry:Drug Manufacturers - General
CEO:Leonard L. Mazur
Employees:285
HQ:Cranford, NY, US
IPO:2022-12-08

No open-market insider trades for CTOR (CITIUS ONCOLOGY, INC.) in the last 365 days.

Why this page may be quiet. Tracefour displays Form 4 open-market purchases (P) and sales (S): the two transaction codes that signal directional conviction. Restricted stock grants, option exercises, gifts, and tax-withholding sales are filed but intentionally not shown: they're disclosure mechanics, not buy/sell decisions.

Many large-cap executives trade through pre-scheduled 10b5-1 plans set months in advance and batch-disclosed each quarter, so the latest filing on EDGAR for a mega-cap can be weeks old without any insider actually choosing to trade in that window.

See all Form 4 filings on SEC EDGAR ↗

Related companies

CITIUS ONCOLOGY, INC. is in the Healthcare sector.